4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-054355
CFO and CBO sold 12,492 shares at an average $8.88 ($110,871)
- CFO and CBO acquired 22,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Molly CFO and CBO | 2023-11-01 | Grant or award | +22,500 | 117,680 | D | ||
| Henderson Molly CFO and CBO | 2023-11-01 | Sale | −811 | $7.80 | $6,326 | 116,869 | D |
| Henderson Molly CFO and CBO | 2023-11-01 | Sale | −11,681 | $8.95 | $104,545 | 105,188 | D |
| Open-market sales · 12,492 sh · avg $8.88 · $110,871 | |||||||
Loading xslF345X05/doc4.xml…